251 related articles for article (PubMed ID: 17517703)
1. Effect of Bifidobacterium bifidum fermented milk on Helicobacter pylori and serum pepsinogen levels in humans.
Miki K; Urita Y; Ishikawa F; Iino T; Shibahara-Sone H; Akahoshi R; Mizusawa S; Nose A; Nozaki D; Hirano K; Nonaka C; Yokokura T
J Dairy Sci; 2007 Jun; 90(6):2630-40. PubMed ID: 17517703
[TBL] [Abstract][Full Text] [Related]
2. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
4. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
[TBL] [Abstract][Full Text] [Related]
5. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.
Myllyluoma E; Veijola L; Ahlroos T; Tynkkynen S; Kankuri E; Vapaatalo H; Rautelin H; Korpela R
Aliment Pharmacol Ther; 2005 May; 21(10):1263-72. PubMed ID: 15882248
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of 13C-urea breath test in clinical use for diagnosis of Helicobacter pylori infection.
Riepl RL; Folwaczny C; Otto B; Klauser A; Blendinger C; Wiebecke B; König A; Lehnert P; Heldwein W
Z Gastroenterol; 2000 Jan; 38(1):13-9. PubMed ID: 10689743
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children.
Gotteland M; Andrews M; Toledo M; Muñoz L; Caceres P; Anziani A; Wittig E; Speisky H; Salazar G
Nutrition; 2008 May; 24(5):421-6. PubMed ID: 18343637
[TBL] [Abstract][Full Text] [Related]
9. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.
Hokkanen S; Kosunen TU; Sarna S; Miettinen A; Salomaa A; Aromaa A; Knekt P; Rautelin HI
Scand J Clin Lab Invest; 2005; 65(4):291-9. PubMed ID: 16076684
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
11. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
12. IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes.
Chang YW; Oh HC; Jang JY; Hwangbo Y; Lee JW; Lee HJ; Joo KR; Dong SH; Kim SS; Kim HJ; Kim BH; Chang R
Scand J Gastroenterol; 2008; 43(10):1184-93. PubMed ID: 18609140
[TBL] [Abstract][Full Text] [Related]
13. Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells.
Shirasawa Y; Shibahara-Sone H; Iino T; Ishikawa F
J Dairy Sci; 2010 Oct; 93(10):4526-34. PubMed ID: 20854986
[TBL] [Abstract][Full Text] [Related]
14. Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections.
Nurgalieva ZZ; Opekun AR; Graham DY
Helicobacter; 2006 Apr; 11(2):69-74. PubMed ID: 16579835
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
16. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
17. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
18. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
[TBL] [Abstract][Full Text] [Related]
19. [Influence of impaired renal function and Helicobacter pylori infection on serum pepsinogen concentrations].
Murakawa M
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):399-405. PubMed ID: 10441989
[TBL] [Abstract][Full Text] [Related]
20. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
